Through the Manitoba Works Capital Incentive, the Manitoba government will provide a rebate of up to $4.2 million over a maximum of 20 years to a commercial greenhouse development in the Parkland region, Minister Eichler announced
VastCon is a biomedical company that envisions of being a global leader in early cancer diagnostics and therapeutics for cancer. Dietary changes inclusive of increased fast-food consumption coupled with sedentary and sluggish life-style have increased the numbers of cancer incidences. Cancer is a burning problem in our society and the key remains prevention and early, timely diagnosis. We at VastCon, hope to improve human health through scientific discoveries and innovation. Our belief is that ‘thinking out of the box’ is the key factor to innovation. VastCon has identified a marker that is present in high amounts in the blood of colorectal cancer (CRC) patients.
Contact Info23 Edington Point Winnipeg R3Y 0A2 MB Canada
P: 1 204 416 8256
F: 1 204 416 8256